Our studies specifically evaluated galectin-1 and -3 due to the evidence suggesting that these two galectin family members are directly involved in the pathogenesis of arthritis and may serve as potential therapeutic targets for OA and RA27, 42, 43, 47. This evidence concerns the gene LGALS1 and Arthritis.